George A. Scangos
2014 - Biogen
In 2014, George A. Scangos earned a total compensation of $18.6M as Chief Executive Officer at Biogen, a 24% increase compared to previous year.
Compensation breakdown
| Change in Pension Value and Nonqualified Deferred Compensation Earnings | $86,634 |
|---|---|
| Non-Equity Incentive Plan | $4,047,313 |
| Salary | $1,375,000 |
| Stock Awards | $12,120,939 |
| Other | $1,001,483 |
| Total | $18,631,369 |
Scangos received $12.1M in stock awards, accounting for 65% of the total pay in 2014.
Scangos also received $86.6K of change in pension value and nonqualified deferred compensation earnings, $4M in non-equity incentive plan, $1.4M in salary and $1M in other compensation.
Rankings
In 2014, George A. Scangos' compensation ranked 143rd out of 13,032 executives tracked by ExecPay. In other words, Scangos earned more than 98.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 143 out of 13,032 | 99th |
Division Manufacturing | 55 out of 4,965 | 99th |
Major group Chemicals And Allied Products | 23 out of 1,690 | 99th |
Industry group Drugs | 20 out of 1,369 | 99th |
Industry Biological Products, Except Diagnostic Substances | 2 out of 241 | 99th |
Source: SEC filing on April 15, 2016.
Scangos' colleagues
We found seven more compensation records of executives who worked with George A. Scangos at Biogen in 2014.
2014
Alfred Sandrock
Biogen
Chief Medical Officer
2014
Adriana Karaboutis
Biogen
EVP, Technology and Business Solutions
2014
Adam Koppel
Biogen
SVP, Chief Strategy Officer
2014
Douglas Williams
Biogen
Former EVP, Research and Development
2014
Paul Clancy
Biogen
Chief Financial Officer
2014
John Cox
Biogen
EVP, Pharmaceutical Operations and Technology
2014
Stuart Kingsley
Biogen